The Suspect in the J6 Pipe Bombing Incident Has Been Captured. Why the...
A Newsom Nihilist Nomination?
The Importance of Being Earnest
Media Make 'Venezuelan Fishermen' the New 'Maryland Father,' and Covering Up the Minnesota...
New Mexico Democrats Push Bill Based on Results of Idiotic Study
Israeli Prime Minister Says He'll Happily Visit NYC Despite Mamdani's Threat to Uphold...
Climate Study That Shaped Global Policy Retracted After Major Error
Inside a Secret Transgender Health Conference: Clinicians Admit They're All Just 'Winging...
U.S. Secret Service Seized 16 Illegal Skimmers, Stopped $16M in Fraud
Two Men Charged After 1,585 Pounds of Meth Found Hidden in Blackberry Shipments...
SCOTUS Upholds New Texas Redistricting Map
Georgia CEO Gets Eight Years for Bribery Scheme Involving Honduran Police Contracts
Appeals Court Grants Administrative Stay to Keep National Guard in D.C.
Santa Monica Doctor Gets 30 Months for Illegally Supplying Ketamine to Actor Matthew...
The Day a Mall Became a Stage for a Hate Movement
Tipsheet

'Revolving Door': What the WH Left Out of Its Announcement About Nominee for NIH Director

President Biden on Monday nominated Dr. Monica Bertagnolli, a surgical oncologist and head of the National Cancer Institute, to be the next director of the National Institutes of Health, but critics say the White House left out an important detail about her background in the administration’s announcement.  

Advertisement

“Dr. Bertagnolli has spent her career pioneering scientific discovery and pushing the boundaries of what is possible to improve cancer prevention and treatment for patients, and ensuring that patients in every community have access to quality care,” Biden said in a statement.
 
“As Director of the National Cancer Institute, Dr. Bertagnolli has advanced my Cancer Moonshot to end cancer as we know it. She has brought together partners and resources from different sectors to launch groundbreaking efforts in cancer prevention and early detection, a national navigation program for childhood cancers, and additional programs to bring clinical trials to more Americans,” the statement continued. “Dr. Bertagnolli is a world-class physician-scientist whose vision and leadership will ensure NIH continues to be an engine of innovation to improve the health of the American people.” 

As Democratic presidential candidate Robert F. Kennedy Jr. and others pointed out, she’s a “revolving door” nominee. 

“From 2015-2021, Bertagnolli received more than 116 grants from Pfizer, totaling $290.8 million. This amount made up 89% of all her. research grants,” he tweeted. 

Kennedy was sure to point out this doesn’t automatically make her “personally corrupt,” but that she will champion Big Pharma’s viewpoints.  

Advertisement

“That is how agencies are captured,” he added, commenting later that he was not surprised the White House left this detail out of the announcement. 


Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement